Product Information
CEFTAZIDIME 1 GM VIAL is a generic product labeled by WG Critical Care, LLC, priced at $3.7045 per EA under NDC 44567023525. Its NADAC has been published 84 times since Nov 20, 2024.
Strength
1 g/1
Manufacturer
WG Critical Care, LLCNDC
44567023525
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
12/17/2025
Active Ingredients
CEFTAZIDIMEApproval Type
Generic (ANDA)
FDA Application
ANDA062640On Market Since
1/31/2013
Pharmacological Classes
Price Statistics
The NADAC for CEFTAZIDIME 1 GM VIAL has been published 84 times since Nov 20, 2024, and over the history we have for it it has declined 4.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.7045 per EA |
|---|---|
| All-time high | $3.8622 (Oct 15, 2025) |
| All-time low | $3.7045 (Oct 22, 2025) |
| 52-week high | $3.8622 |
| 52-week low | $3.7045 |
| Median price | $3.8622 |
| Average price | $3.7946 |
| Largest weekly change | -4.1% (Oct 22, 2025) |
| Weeks tracked | 84 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Ceftazidime market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CEFTAZIDIME 1 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFTAZIDIME 1 GM VIAL, manufactured by WG Critical Care, LLC, is $3.7045 per EA (NDC 44567023525), effective Jun 24, 2026.
How has the price of CEFTAZIDIME 1 GM VIAL changed over time?
Over the history we have for it, the NADAC for CEFTAZIDIME 1 GM VIAL has declined 4.1%. It has been tracked across 84 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for CEFTAZIDIME 1 GM VIAL?
Since Nov 20, 2024, the NADAC for CEFTAZIDIME 1 GM VIAL has ranged from a low of $3.7045 (Oct 22, 2025) to a high of $3.8622 (Oct 15, 2025), with a median of $3.8622 per EA.
Are there cheaper alternatives to CEFTAZIDIME 1 GM VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CEFTAZIDIME 1 GM VIAL, so no direct lower-cost alternative is listed.
Who manufactures CEFTAZIDIME 1 GM VIAL?
CEFTAZIDIME 1 GM VIAL (NDC 44567023525) is labeled by WG Critical Care, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification